CytomX Therapeutics Announces Full-Year 2017 Financial Results and Provides Operational Update Pharmaceutical Investing
XOMA Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update Biotech Investing
BriaCell Announces Proposed Investment by Leading Biotech Funds and Concurrent Non-Brokered Financing for aggregate gross proceeds of up to $4.8 Million Biotech Investing
Aptose Biosciences Announces Exclusive License Agreement for Dual BET/Kinase Targeting Program With OHM Oncology Biotech Investing
Tetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results Pharmaceutical Investing
